Nimbus Therapeutics

About:

Nimbus Therapeutics uses computational technology to create selective small molecule therapeutics.

Website: http://nimbustx.com

Twitter/X: NimbusTx

Top Investors: Schrödinger, RA Capital Management, Google Ventures, SV Health Investors, Biotechnology Value Fund

Description:

Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical-stage company. Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Mass., that is pioneering a new computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. Nimbus Therapeutics designs highly selective and potent medicines to disrupt known drivers of serious diseases, including metabolic disease, cancer, and immune-inflammatory disorders.

Total Funding Amount:

$637M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)nimbustx.com

Founders:

Bruce Booth

Number of Employees:

51-100

Last Funding Date:

2023-09-06

IPO Status:

Private

© 2025 bioDAO.ai